Pfizer Inc.


Market Cap$156.68B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Pfizer Inc.Pfizer Inc.-505.45.87%0%3.10.8

Earnings Call Q4 2023

January 30, 2024 - AI Summary

Pfizer reported full-year 2023 revenues of $58.5 billion, achieving 7% operational growth (excluding COVID products), in line with expectations.
The decline in revenue from COVID products significantly impacted the overall results, leading to a 41% year-over-year decrease in revenues.
Adjusted diluted earnings per share for 2023 were $1.84, down 72% compared to the previous year, primarily due to lower sales of Comirnaty and Paxlovid.

Exclusive for Stockcircle Pro members

Sign upSign Up

Target Price by Analysts

30.8% upsidePfizer Target Price DetailsTarget Price

Current Fair Value

132.3% upside

Undervalued by 132.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$156.68 Billion
Enterprise Value$214.29 Billion
Dividend Yield$1.6243 (5.87%)
Earnings per Share$-0.05
Outstanding Shares5,666,592,898
Avg 30 Day Volume34,715,955


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-505.42
Price to Sales3.06
Price to Book Ratio1.72
Enterprise Value to Revenue3.89
Enterprise Value to EBIT86.37
Enterprise Value to Net Income-692
Total Debt to Enterprise0.32
Debt to Equity0.75

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Pfizer Inc.

CEO: Albert Bourla